These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 27868229)

  • 1. The synthesis of a tritium, carbon-14, and stable isotope-labeled cathepsin C inhibitors.
    Allen P; Bragg RA; Caffrey M; Ericsson C; Hickey MJ; Kingston LP; Elmore CS
    J Labelled Comp Radiopharm; 2017 Feb; 60(2):124-129. PubMed ID: 27868229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of 2 C-14 labeled cathepsin C inhibitors: The use of a cyanide to displace a Benzotriazole.
    Kingston L; Bergare J; Lönn H; Ericsson C; Grönberg G; Chen S; Elmore CS
    J Labelled Comp Radiopharm; 2017 May; 60(6):294-301. PubMed ID: 28324911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiosynthesis of
    Vaidyanathan S; Reed A; Du J
    J Labelled Comp Radiopharm; 2021 Jul; 64(9):356-362. PubMed ID: 34050966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The synthesis of tritium, carbon-14 and stable isotope labelled selective estrogen receptor degraders.
    Bragg RA; Bushby N; Ericsson C; Kingston LP; Ji H; Elmore CS
    J Labelled Comp Radiopharm; 2016 Sep; 59(11):454-61. PubMed ID: 27558079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of [
    Queen AE; Hesk D; Lindsay DM; Kerr WJ; Rehder K; Fennell T; Mascarella W; Zhong D; Runyon S
    J Labelled Comp Radiopharm; 2020 Apr; 63(4):196-202. PubMed ID: 32017204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of selectively labeled histidine and its methylderivatives with deuterium, tritium, and carbon-14.
    Šamonina-Kosicka J; Kańska M
    J Labelled Comp Radiopharm; 2013 May; 56(6):317-20. PubMed ID: 24285411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbon-13 and carbon-14 labeled dabigatran etexilate and tritium labeled dabigatran.
    Latli B; Kiesling R; Aßfalg S; Chevliakov M; Hrapchak M; Campbell S; Gonnella N; Busacca CA; Senanayake CH
    J Labelled Comp Radiopharm; 2016 Dec; 59(14):648-656. PubMed ID: 27146196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of potent and selective Cathepsin C inhibitors free of aortic binding liability by application of a conformational restriction strategy.
    Banerjee A; Velagaleti R; Patil S; Pawar M; Yadav P; Kadam P; Qadri MM; Chakraborti S; Saini JS; Behera DB; Karanjai K; Iyer PS; Gharat LA; Das S
    Bioorg Med Chem Lett; 2021 Sep; 47():128202. PubMed ID: 34139325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site selective syntheses of [(3)H]omeprazole using hydrogen isotope exchange chemistry.
    Pollack SR; Schenk DJ
    J Labelled Comp Radiopharm; 2015; 58(11-12):433-41. PubMed ID: 26380956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of carbon-14 and stable isotope labeled Avagacestat: a novel gamma secretase inhibitor for the treatment of Alzheimer's disease.
    Burrell RC; Easter JA; Cassidy MP; Gillman KW; Olson RE; Bonacorsi SJ
    J Labelled Comp Radiopharm; 2014 Aug; 57(10):600-5. PubMed ID: 25196195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aortic Binding of AZD5248: Mechanistic Insight and Reactivity Assays To Support Lead Optimzation.
    Bragg RA; Brocklehurst S; Gustafsson F; Goodman J; Hickling K; MacFaul PA; Swallow S; Tugwood J
    Chem Res Toxicol; 2015 Oct; 28(10):1991-9. PubMed ID: 26351880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The synthesis of one H-2 labeled and two H-3 labeled leukotriene C4 synthase inhibitors.
    Bergare J; Kingston L; Guly DJ; Dolan J; Lewis RJ; Elmore CS
    J Labelled Comp Radiopharm; 2020 Aug; 63(10):434-441. PubMed ID: 32441366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review: Self-radiolysis of compounds containing tritium and carbon-14.
    Wolf JR
    J Labelled Comp Radiopharm; 2021 Jun; 64(8):286-335. PubMed ID: 33439502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syntheses of (3) H-labeled, (14) C-labeled, and (2) H4 -labeled SCH 444877, phosphodiesterase type 5 inhibitors.
    Ren S; Hesk D; McNamara P; Koharski D; Hendershot S
    J Labelled Comp Radiopharm; 2013; 56(9-10):480-4. PubMed ID: 24285525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and application of isocyanates radiolabeled with carbon-11.
    Wilson AA; Garcia A; Houle S; Sadovski O; Vasdev N
    Chemistry; 2011 Jan; 17(1):259-64. PubMed ID: 21207622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tritiation of nonpeptide substance P antagonist CP-96,345 and its azido analogue. Synthetic and characterization details.
    Egan JA; Filer CN
    Appl Radiat Isot; 2003; 59(5-6):333-5. PubMed ID: 14622931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphinan alkaloids labeled with tritium: synthesis and applications.
    Filer CN
    J Labelled Comp Radiopharm; 2013 Nov; 56(13):639-48. PubMed ID: 25196025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic Carbon Isotope Exchange of Pharmaceuticals with Labeled CO
    Destro G; Loreau O; Marcon E; Taran F; Cantat T; Audisio D
    J Am Chem Soc; 2019 Jan; 141(2):780-784. PubMed ID: 30586301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [¹¹C]NS9531, [¹¹C]NS9762 and [¹¹C]NS6417, specific SERT tracers: pre-clinical evaluation in pigs and optimization of synthesis conditions using [¹¹C]methyl triflate.
    Dam JH; Bender D; Peters D; Någren K
    Nucl Med Biol; 2016 Jan; 43(1):42-51. PubMed ID: 26702786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus serine protease: synthesis of radioactive and stable isotope-labeled potent inhibitors.
    Latli B; Hrapchak M; Gorys V; Llinàs-Brunet M; Campbell SS; Song J; Senanayake CH
    J Labelled Comp Radiopharm; 2014 May; 57(5):350-7. PubMed ID: 24700697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.